510(k) K010891
K010891 is an FDA 510(k) premarket notification submitted by Digene Corp. for the device "MODIFICATION TO HYBRID CAPTURE II CT/GC TEST, MODEL 03M90-01". The FDA issued a decision of Substantially Equivalent on September 25, 2001. The device falls under product code LSK (Dna-Reagents, Chlamydia), a Class I device regulated under 21 CFR 866.3120. Digene Corp. has at least 8 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 25, 2001
- Date Received
- March 26, 2001
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Dna-Reagents, Chlamydia
- Device Class
- Class I
- Regulation Number
- 866.3120
- Review Panel
- MI
- Submission Type